Westside Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.8K | Hold |
1,160
| – | – | 0.01% | 419 |
|
|
2025
Q1 | $82K | Sell |
1,160
-150
| -11% | -$10.6K | 0.02% | 336 |
|
|
2024
Q4 | $86.1K | Hold |
1,310
| – | – | 0.02% | 325 |
|
|
2024
Q3 | $92.1K | Buy |
1,310
+100
| +8% | +$7.03K | 0.02% | 322 |
|
|
2024
Q2 | $99.6K | Hold |
1,210
| – | – | 0.02% | 308 |
|
|
2024
Q1 | $106K | Hold |
1,210
| – | – | 0.03% | 287 |
|
|
2023
Q4 | $117K | Hold |
1,210
| – | – | 0.03% | 261 |
|
|
2023
Q3 | $107K | Hold |
1,210
| – | – | 0.03% | 265 |
|
|
2023
Q2 | $105K | Sell |
1,210
-600
| -33% | -$52K | 0.03% | 267 |
|
|
2023
Q1 | $176K | Sell |
1,810
-400
| -18% | -$38.9K | 0.05% | 220 |
|
|
2022
Q4 | $228 | Sell |
2,210
-160
| -7% | -$17 | ﹤0.01% | 314 |
|
|
2022
Q3 | $6.98K | Sell |
2,370
-1,550
| -40% | -$4.56K | 0.02% | 213 |
|
|
2022
Q2 | $6.66K | Hold |
3,920
| – | – | 0.02% | 207 |
|
|
2022
Q1 | $6.64K | Hold |
3,920
| – | – | 0.01% | 208 |
|
|
2021
Q4 | $6.51K | Sell |
3,920
-800
| -17% | -$1.33K | 0.01% | 200 |
|
|
2021
Q3 | $6.53K | Buy |
4,720
+200
| +4% | +$277 | 0.02% | 202 |
|
|
2021
Q2 | $7.05K | Buy |
4,520
+650
| +17% | +$1.01K | 0.02% | 194 |
|
|
2021
Q1 | $6.33K | Buy |
3,870
+3,510
| +975% | +$5.74K | 0.02% | 189 |
|
|
2020
Q4 | $31 | Buy |
+360
| New | +$31 | ﹤0.01% | 382 |
|